These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12426058)

  • 81. Being too inclusive about synuclein inclusions.
    Isacson O; Mendez I
    Nat Med; 2010 Sep; 16(9):960-1; author reply 961. PubMed ID: 20823871
    [No Abstract]   [Full Text] [Related]  

  • 82. The issue of waste disposal in Parkinson's disease pathogenesis.
    Parnetti L; Bellomo G
    Mov Disord; 2019 Jul; 34(7):985. PubMed ID: 31145819
    [No Abstract]   [Full Text] [Related]  

  • 83. Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol.
    Meredith GE; Totterdell S; Potashkin JA; Surmeier DJ
    Parkinsonism Relat Disord; 2008; 14 Suppl 2(Suppl 2):S112-5. PubMed ID: 18585085
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mutant mice with rod-specific VPS35 deletion exhibit retinal α-synuclein pathology-associated degeneration.
    Fu C; Yang N; Chuang JZ; Nakajima N; Iraha S; Roy N; Wu Z; Jiang Z; Otsu W; Radu RA; Yang HH; Lee MP; Worgall TS; Xiong WC; Sung CH
    Nat Commun; 2024 Jul; 15(1):5970. PubMed ID: 39043666
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission.
    Lage L; Rodriguez-Perez AI; Villar-Cheda B; Labandeira-Garcia JL; Dominguez-Meijide A
    NPJ Parkinsons Dis; 2024 Feb; 10(1):37. PubMed ID: 38368444
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cogs in the autophagic machine-equipped to combat dementia-prone neurodegenerative diseases.
    de Wet S; Theart R; Loos B
    Front Mol Neurosci; 2023; 16():1225227. PubMed ID: 37720551
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy.
    Finkelstein DI; Shukla JJ; Cherny RA; Billings JL; Saleh E; Stefanova N; Barnham KJ; Adlard PA
    J Parkinsons Dis; 2022; 12(1):105-115. PubMed ID: 34744051
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Reverse engineering Lewy bodies: how far have we come and how far can we go?
    Fares MB; Jagannath S; Lashuel HA
    Nat Rev Neurosci; 2021 Feb; 22(2):111-131. PubMed ID: 33432241
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Raman spectral imaging of
    Watson MD; Flynn JD; Lee JC
    Biophys Chem; 2021 Feb; 269():106528. PubMed ID: 33418468
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Membrane Interactions of α-Synuclein Probed by Neutrons and Photons.
    Kaur U; Lee JC
    Acc Chem Res; 2021 Jan; 54(2):302-310. PubMed ID: 33415971
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Role of Glial Mitochondria in α-Synuclein Toxicity.
    Jeon YM; Kwon Y; Jo M; Lee S; Kim S; Kim HJ
    Front Cell Dev Biol; 2020; 8():548283. PubMed ID: 33262983
    [TBL] [Abstract][Full Text] [Related]  

  • 92. GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib.
    Li J; Ma S; Chen J; Hu K; Li Y; Zhang Z; Su Z; Woodgett JR; Li M; Huang Q
    Front Mol Neurosci; 2020; 13():81. PubMed ID: 32581704
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease.
    Haque A; Samantaray S; Knaryan VH; Capone M; Hossain A; Matzelle D; Chandran R; Shields DC; Farrand AQ; Boger HA; Banik NL
    Exp Neurol; 2020 Aug; 330():113315. PubMed ID: 32302678
    [TBL] [Abstract][Full Text] [Related]  

  • 94. α-Synuclein: A Multifunctional Player in Exocytosis, Endocytosis, and Vesicle Recycling.
    Huang M; Wang B; Li X; Fu C; Wang C; Kang X
    Front Neurosci; 2019; 13():28. PubMed ID: 30745863
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Interplay between α-synuclein amyloid formation and membrane structure.
    O'Leary EI; Lee JC
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):483-491. PubMed ID: 30287222
    [TBL] [Abstract][Full Text] [Related]  

  • 96. An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration.
    Moreno-García A; Kun A; Calero O; Medina M; Calero M
    Front Neurosci; 2018; 12():464. PubMed ID: 30026686
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Revisiting the Paraquat-Induced Sporadic Parkinson's Disease-Like Model.
    Bastías-Candia S; Zolezzi JM; Inestrosa NC
    Mol Neurobiol; 2019 Feb; 56(2):1044-1055. PubMed ID: 29862459
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.
    O'Leary EI; Jiang Z; Strub MP; Lee JC
    J Biol Chem; 2018 Jul; 293(28):11195-11205. PubMed ID: 29853639
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Membranes as modulators of amyloid protein misfolding and target of toxicity.
    Rawat A; Langen R; Varkey J
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1863-1875. PubMed ID: 29702073
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Stimulation of α-synuclein amyloid formation by phosphatidylglycerol micellar tubules.
    Jiang Z; Flynn JD; Teague WE; Gawrisch K; Lee JC
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1840-1847. PubMed ID: 29501608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.